Recent progress in hemorrhagic moyamoya disease

References

• Suzuki J, Takaku A. Cerebrovascular ‘moyamoya’ disease. Disease showing abnormal net-like vessels in base of brain – Arch Neurol 1969;20:288–99.
   PubMed Web of Science ®Google Scholar
• Hoshino H, Izawa Y, Suzuki N. Epidemiological features of moyamoya disease in Japan. Neurol Med Chir (Tokyo) 2012;52: 295–8.
   PubMed Web of Science ®Google Scholar
• Matsushima Y, Qian L, Aoyagi M, et al. Comparison of moyamoya disease in Japan and moyamoya disease (or syndrome) in the People's Republic of China – Clin Neurol Neurosurg 1997;99: S19–22.
   PubMedGoogle Scholar
• Baba T, Houkin K, Kuroda S, et al. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 2008;79:900–4.
   PubMed Web of Science ®Google Scholar
• lkezaki K, Han DH, Kawano T, et al. A clinical comparison of definite moyamoya diseases between South Korea and Japan – Stroke 1997;28:2513–7.
   PubMedGoogle Scholar
• Miao W, Zhao PL, Zhang YS, et al. Epidemiological and clinical features of Moyamoya disease in Nanjing, China – Clin Neurol Neurosurg 2010;112:199–203.
   PubMed Web of Science ®Google Scholar
• Duan L, Bao XY, Yang WZ, et al. Moyamoya disease in China: its clinical features and outcomes – Stroke 2012;43:56–60.
   PubMed Web of Science ®Google Scholar
• Fukui M. Current state of study on moyamoya disease in Japan. Surg Neurol 1997;47:138–43.
   PubMedGoogle Scholar
• Yonekawa Y, Taub E. Moyamoya disease: status 1998. Neurologist 1999;5:13–23.
   Google Scholar
• Ikeda H, Sasaki T, Yoshimoto T, et al. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26 – Am J Hum Genet 1999;64:533–7.
   PubMed Web of Science ®Google Scholar
• Inoue TK, Ikezaki K, Sasazuki T, et al. Linkage analysis of moyamoya disease on chromosome 6 – J Child Neurol 2000;15:179–82.
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Tada M, Houkin K, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 2000;31:930–5.
   PubMed Web of Science ®Google Scholar
• Sakurai K, Horiuchi Y, Ikeda H, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23 – J Hum Genet 2004;49:278–81.
   PubMed Web of Science ®Google Scholar
• Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene – J Hum Genet 2011;56:34–40.
   PubMed Web of Science ®Google Scholar
• Morito D, Nishikawa K, Hoseki J, et al. Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state. Sci Rep 2014;4:4442.
   PubMed Web of Science ®Google Scholar
• Wu Z, Jiang H, Zhang L, et al. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population – PLoS One 2012;7:e48179 .
   PubMed Web of Science ®Google Scholar
• Takekawa Y, Umezawa T, Ueno Y, et al. Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease. Neuropathology 2004; 24:236–42.
   PubMed Web of Science ®Google Scholar
• Lin R, Xie Z, Zhang J, et al. Clinical and immunopathological features of Moyamoya disease. PLoS One 20127:e36386.
   Google Scholar
• Morioka M, Hamada J, Kawano T, et al. Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of haemorrhage in adult moyamoya patients – Stroke 2003;34:90–5.
   PubMed Web of Science ®Google Scholar
• Kikuta K, Takagi Y, Nozaki K, et al. Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study – J Neurosurg 2005;102:470–5.
   PubMedGoogle Scholar
• Kikuta K, Takagi Y, Nozaki K, et al. The presence of multiple microbleeds as a predictor of subsequent cerebral haemorrhage in patients with moyamoya disease – Neurosurgery 2008;62: 104–11.
   PubMed Web of Science ®Google Scholar
• Sun W, Yuan C, Liu W, et al. Asymptomatic cerebral microbleeds in adult patients with moyamoya disease: a prospective cohort study with 2 years of follow-up. Cerebrovasc Dis 2013;35:469–75.
   PubMed Web of Science ®Google Scholar
• Scott RM, Smith JL, Robertson RL, et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004;100:142–9.
   PubMed Web of Science ®Google Scholar
• Bowen MD, Burak CR, Barron TF. Childhood ischemic stroke in a nonurban population. J Child Neurol 2005;20:194–7.
   PubMed Web of Science ®Google Scholar
• Mesiwala AH, Sviri G, Fatemi N, et al. Long-term outcome of superficial temporal arteryemiddle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg Focus 2008;24:E15.
   PubMed Web of Science ®Google Scholar
• Ikezaki K. Rational approach to treatment of moyamoya disease in childhood. J Child Neurol 2000;15:350–6.
   PubMedGoogle Scholar
• Fei D, Jizong Z, Dong Z et a1. Long-term effects of surgical therapy and conservative treatment on moyamoya disease. Chin J Curr Clin Med 2005;3:1018–20.
   Google Scholar
• Liu X, Zhang D, Shuo W, et al. Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease – J Neurol Neurosurg Psychiatry 2013;84:258–65.
   PubMed Web of Science ®Google Scholar
• Jiang H, Ni W, Xu B, et al. Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass. J Neurosurg 2014;15:1–8.
   Google Scholar
• Choi IJ, Cho SJ, Chang JC, et al. Angiographic results of indirect and combined bypass surgery for adult moyamoya disease – J Cerebrovasc Endovasc Neurosurg 2012;14:216–22.
   PubMedGoogle Scholar
• Bao XY, Duan L, Li DS et al. Clinical features, surgical treatment and long-term outcome in adult patients with moyamoya disease in China. Cerebrovasc Dis 2012;34:305–13.
   PubMedGoogle Scholar
• Su SH, Hai J, Zhang L, et al. Assessment of cognitive function in adult patients with haemorrhagic moyamoya disease who received no surgical revascularization – Eur J Neurol 2013;20: 1081–7.
   PubMedGoogle Scholar
• Su SH, Hai J, Zhang L, et al. Quality of life and psychological impact in adult patients with haemorrhagic moyamoya disease who received no surgical revascularization – J Neurol Sci 2013; 328:32–6.
   PubMedGoogle Scholar
• Karzmark P, Zeifert PD, Bell-Stephens TE, et al. Neurocognitive impairment in adults with moyamoya disease without stroke – Neurosurgery 2012;70:634–8.
   PubMedGoogle Scholar